69 related articles for article (PubMed ID: 17502793)
1. Open trials in psychiatry: comments on article by Uchida et Al.
Magalhães PV
J Clin Psychopharmacol; 2007 Jun; 27(3):318; author reply 318-9. PubMed ID: 17502793
[No Abstract] [Full Text] [Related]
2. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
Hashimoto K
J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
[No Abstract] [Full Text] [Related]
3. Restless legs syndrome associated with the combined use of duloxetine plus paroxetine.
Nikolaou KN; Michopoulos I; Douzenis A; Papazahos C; Papageorgiou C; Gournellis R
J Clin Psychopharmacol; 2015 Jun; 35(3):345-6. PubMed ID: 25815756
[No Abstract] [Full Text] [Related]
4. Switching, combination, and augmentation strategies for major depressive disorder.
Papakostas GI
Ann Clin Psychiatry; 2010 Nov; 22(4 Suppl 3):S9-14. PubMed ID: 21180666
[No Abstract] [Full Text] [Related]
5. Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
Uchida H; Suzuki T; Watanabe K; Kashima H
Psychiatry Clin Neurosci; 2009 Feb; 63(1):126. PubMed ID: 19154222
[No Abstract] [Full Text] [Related]
6. Re: Managing depression refractory to SSRIs.
Dewan V
Can J Psychiatry; 2000 Nov; 45(9):844. PubMed ID: 11143836
[No Abstract] [Full Text] [Related]
7. Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies.
Thase ME
CNS Spectr; 2009 Mar; 14(3 Suppl 4):7-10. PubMed ID: 19407714
[No Abstract] [Full Text] [Related]
8. Urinary retention with reboxetine-fluoxetine combination in a young man.
Benazzi F
Can J Psychiatry; 2000 Dec; 45(10):936. PubMed ID: 11190365
[No Abstract] [Full Text] [Related]
9. How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.
Preskorn SH
J Psychiatr Pract; 2008 May; 14(3):170-5. PubMed ID: 18520787
[No Abstract] [Full Text] [Related]
10. The modern pharmacopoeia: a return to depressive realism?
Goldberg JF
Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
[No Abstract] [Full Text] [Related]
11. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
Gitlin MJ
CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929
[No Abstract] [Full Text] [Related]
12. Initial treatment approaches for patients with major depressive disorder.
Papakostas GI
J Clin Psychiatry; 2009 Jun; 70(6):e18. PubMed ID: 19573474
[TBL] [Abstract][Full Text] [Related]
13. Combination antidepressants are not yet proven therapy in the treatment of depression.
Olver J; Ellen S; Norman T
Australas Psychiatry; 2007 Jun; 15(3):248-9. PubMed ID: 17516193
[No Abstract] [Full Text] [Related]
14. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
Cassidy F
Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
[No Abstract] [Full Text] [Related]
16. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of a major depressive episode.
Thase ME
J Clin Psychiatry; 2009 Oct; 70(10):e37. PubMed ID: 19906336
[TBL] [Abstract][Full Text] [Related]
18. The STAR*D trial: the 300 lb gorilla is in the room, but does it block all the light?
Hatcher S
Evid Based Ment Health; 2008 Nov; 11(4):97-9. PubMed ID: 18952951
[No Abstract] [Full Text] [Related]
19. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
Hamoda HM; Osser DN
Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.
Ehde DM; Kraft GH; Chwastiak L; Sullivan MD; Gibbons LE; Bombardier CH; Wadhwani R
Gen Hosp Psychiatry; 2008; 30(1):40-8. PubMed ID: 18164939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
